PCF 全称 PhenoCycler-Fusion，是 Akoya Biosciences 推出的超多重空间单细胞蛋白组学平台，是 CODEX 技术的升级版。它在组织切片原位实现蛋白层面的"高通量成像"，被 Nature Methods 评为 2024 年度技术之一。

华盈生物作为Akoya Biosciences公司认证的PhenoCycler-Fusion技术服务商，已建立成熟的服务体系：拥有100+抗体库，可检测多种组织类型，合作客户在Cell、STTT、Sci Transl Med等国际高水平期刊发表多篇文章。

本期我们挑选了多篇PCF在肺癌研究中应用的高分案例，汇总了这些研究中PCF检测的抗体目录信息，以供大家参考。

| 参考文献

1. Wang, GZ., Wang, Z., Bai, SH. et al. Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers. Sig Transduct Target Ther 10, 290 (2025).

2. Li, Z., Li, Y., Xiang, J. et al. AI-enabled virtual spatial proteomics from histopathology for interpretable biomarker discovery in lung cancer. Nat Med 32, 231–244 (2026).

3. Li Y, Li Z, Quinton R et al. Cellular architecture and neighborhood-informed virtual spatial tumor profiling from histopathology. Cell. 2026;189(14):4241-4259.e9.

4. Meyerhoff RR, Chen A, O'Brien J, et al. Tumor-infiltrating plasma cell profiling after PD-1 blockade reveals tumor-specific antibodies. Cancer Cell. 2026:S1535-6108(26)00310-7.

5. Chen H, Deng C, Gao J et al. Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer. Cancer Cell. 2025;43(3):519-536.e5.

6. Nandigama R, Cheikh BB, Wilhelm J et al. Spatial proteomics profiling reveals oncogene-specific immune niches and prognostic markers in NSCLC. Am J Respir Crit Care Med. 2026:aamag330.

7. Aung, T.N., Monkman, J., Warrell, J. et al. Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer. Nat Genet 57, 2482–2493 (2025).

8. Monkman, J., Kilgallon, A., Lawler, C. et al. Metabolic characterization of tumor-immune interactions by multiplexed immunofluorescence reveals spatial mechanisms of immunotherapy response in non-small cell lung carcinoma (NSCLC). Nat Commun 17, 837 (2026).

9. Takano, Y., Suzuki, J., Nomura, K. et al. Spatially resolved gene expression profiling of tumor microenvironment reveals key steps of lung adenocarcinoma development. Nat Commun 15, 10637 (2024).

10. Haga, Y., Sakamoto, Y., Kajiya, K. et al. Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma. Nat Commun 14, 8375 (2023).

11. Zheng Y, Sadée C, Ozawa M et al. Single-cell multimodal analysis reveals tumor microenvironment predictive of treatment response in non-small cell lung cancer. Sci Adv. 2025;11(21):eadu2151.